Kymera Therapeutics, Inc.
KYMRNasdaqCIK 1815442HealthcareFiscal year ends Dec 31
Reports and events: 123 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2907:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-436965 |
| 2026-08-0507:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-333849 |
| 2026-08-0507:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-333834 |
| 2026-07-2716:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-318078 |
| 2026-06-2618:43 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-26-001687 |
| 2026-06-2507:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-281817 |
| 2026-06-2416:07 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-281051 |
| 2026-06-0816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-261698 |
| 2026-04-3007:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-193967 |
| 2026-04-3007:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-193957 |
| 2026-04-2916:05 ET | DEF 14A | Proxy statementPeriod 2026-06-24 | 0001193125-26-191495 |
| 2026-03-2716:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-129170 |
| 2026-02-2608:22 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-073561 |
| 2026-02-2607:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-073395 |
| 2026-02-2607:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-073386 |
| 2026-01-1307:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-011104 |
| 2025-12-1518:07 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000921895-25-003346 |
| 2025-12-1117:27 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-120356 |
| 2025-12-1017:17 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-314422 |
| 2025-12-0808:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-310670 |
| 2025-12-0807:17 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310572 |
| 2025-11-0407:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-263550 |
| 2025-11-0407:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263540 |
| 2025-09-0307:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-194481 |
| 2025-08-1107:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106229 |
| 2025-08-1107:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106227 |
| 2025-06-3020:26 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-064298 |
| 2025-06-2716:55 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-151393 |
| 2025-06-2716:32 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-151345 |
| 2025-06-2507:12 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-146135 |
| 2025-06-2507:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-146134 |
| 2025-06-0208:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-132838 |
| 2025-06-0207:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-132760 |
| 2025-05-0907:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-067498 |
| 2025-05-0907:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-116443 |
| 2025-04-2916:05 ET | DEF 14A | Proxy statementPeriod 2025-06-25 | 0001193125-25-103767 |
| 2025-03-0316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-044151 |
| 2025-02-2707:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-028355 |
| 2025-02-2707:13 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-037588 |
| 2025-01-1416:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-006124 |
| 2024-10-3107:45 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-119249 |
| 2024-10-3107:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-119245 |
| 2024-08-2216:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-091998 |
| 2024-08-2017:24 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-203755 |
| 2024-08-0707:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-092275 |
| 2024-08-0707:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092272 |
| 2024-07-0816:22 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-176312 |
| 2024-06-2017:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-164550 |
| 2024-05-0207:15 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-051567 |
| 2024-05-0207:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-051566 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:17 ET. Listed shows no prices and gives no investment advice.